Co-founder and Partner, Life Sciences & Corporate

James is a leading transactional venture capital lawyer, advising entrepreneurs, companies and investors through the funding life-cycle.

Since qualifying as a lawyer in 2000, James has helped entrepreneurs, high-growth technology based companies and investors navigate their way through multiple rounds of financing, growth, scale-up and ultimately exit/liquidity event.

Over the years, James has also been one of the most prolific University spin-out lawyers to life sciences companies and continues to advise on spin-out activity.

As a close adviser to many companies and investors, James is also General Counsel to the following companies:

— Bioven – an immuno-oncology business with a lead product in phase III trials and a pipeline of pre-clinical assets.

— Mologic Limited – a point-of-care diagnostics spin-out from Alere.

— Grampian BioPartners – a specialist life science business angel syndicate, able to act as a micro-lead on specialist life-science deals.

James is a graduate of both St Andrews University (BSc Hons) and Edinburgh University (LLB), and, as a Scottish qualified lawyer, holds a committee position on the Society of Scottish Lawyers in London and is a Writer to Her Majesty’s Signet.

James is ranked as a recommended lawyer in the 2017 edition of Legal 500 for Venture Capital.